Hippocampal atrophy in relapsing-remitting and primary progressive MS: a comparative study

Background: In multiple sclerosis (MS), demyelination and neuroaxonal damage are seen in the hippocampus, and MRI has revealed hippocampal atrophy. Objectives: To investigate and compare hippocampal volume loss in patients with relapsing—remitting MS (RRMS) and primary progressive MS (PPMS) using manual volumetry, and explore its association with memory dysfunction. Methods: Hippocampi were manually delineated on volumetric MRI of 34 patients with RRMS, 23 patients with PPMS and 18 controls. Patients underwent neuropsychological tests of verbal and visuospatial recall memory. Linear regression was used to compare hippocampal volumes between subject groups, and to assess the association with memory function. Results: Hippocampal volumes were smaller in MS patients compared with controls, and were similar in patients with RRMS and PPMS. The mean decrease in hippocampal volume in MS patients was 317 mm3 (9.4%; 95% CI 86 to 549; p = 0.008) on the right and 284 mm3 (8.9%; 95% CI 61 to 508; p = 0.013) on the left. A borderline association of hippocampal volume with memory performance was observed only in patients with PPMS. Conclusion: Hippocampal atrophy occurs in patients with RRMS and PPMS. Factors additional to hippocampal atrophy may impact on memory performance.

[1]  D. Ramasamy,et al.  Extent of cerebellum, subcortical and cortical atrophy in patients with MS A case-control study , 2009, Journal of the Neurological Sciences.

[2]  Martin Styner,et al.  A comparison of automated segmentation and manual tracing for quantifying hippocampal and amygdala volumes , 2009, NeuroImage.

[3]  G. Koutsis,et al.  Cognitive impairment in different MS subtypes and clinically isolated syndromes , 2008, Journal of the Neurological Sciences.

[4]  Eui-Cheol Nam,et al.  Validation of hippocampal volumes measured using a manual method and two automated methods (FreeSurfer and IBASPM) in chronic major depressive disorder , 2008, Neuroradiology.

[5]  G Tedeschi,et al.  Brain atrophy and lesion load in a large population of patients with multiple sclerosis , 2005, Neurology.

[6]  Mara Cercignani,et al.  Grey and white matter volume changes in early primary progressive multiple sclerosis: a longitudinal study. , 2005, Brain : a journal of neurology.

[7]  Frederik Barkhof,et al.  In vivo MR imaging of hippocampal lesions in multiple sclerosis , 2008, Journal of magnetic resonance imaging : JMRI.

[8]  D. Ramasamy,et al.  Memory impairment in multiple sclerosis: correlation with deep grey matter and mesial temporal atrophy , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[9]  R. Snaith,et al.  The hospital anxiety and depression scale. , 2013, Acta psychiatrica Scandinavica.

[10]  Truman R Brown,et al.  Linking hippocampal structure and function to memory performance in an aging population. , 2009, Archives of neurology.

[11]  F. Barkhof,et al.  Accumulation of cortical lesions in MS: relation with cognitive impairment , 2009, Multiple sclerosis.

[12]  S. Burgmans,et al.  The posterior parahippocampal gyrus is preferentially affected in age-related memory decline , 2011, Neurobiology of Aging.

[13]  Hillary C. M. Nelson.  The National Adult Reading Test , 1982 .

[14]  Marco Rovaris,et al.  Conventional and magnetization transfer MRI predictors of clinical multiple sclerosis evolution: a medium-term follow-up study. , 2003, Brain : a journal of neurology.

[15]  Richard Nicholas,et al.  Substantial Archaeocortical Atrophy and Neuronal Loss in Multiple Sclerosis , 2009, Brain pathology.

[16]  N. Burgess,et al.  The hippocampus and memory: insights from spatial processing , 2008, Nature Reviews Neuroscience.

[17]  P Dastidar,et al.  Cognitive dysfunction in primary progressive multiple sclerosis: a neuropsychological and MRI study , 2009, Multiple sclerosis.

[18]  J. Barnes,et al.  A comparison of methods for the automated calculation of volumes and atrophy rates in the hippocampus , 2008, NeuroImage.

[19]  S Ropele,et al.  Magnetization transfer ratio measurement in multiple sclerosis normal-appearing brain tissue: limited differences with controls but relationships with clinical and MR measures of disease , 2007, Multiple sclerosis.

[20]  N. Raz,et al.  Memory in multiple sclerosis: Contextual encoding deficits , 2002, Journal of the International Neuropsychological Society.

[21]  Rohit Bakshi,et al.  Gray and white matter brain atrophy and neuropsychological impairment in multiple sclerosis , 2006, Neurology.

[22]  Michael Weiner,et al.  Automated 3d Mapping of Baseline and 12-month Associations between Three Verbal Memory Measures and Hippocampal Atrophy in 490 Adni Subjects and the Alzheimer's Disease Neuroimaging Initiative , 2022 .

[23]  M. Moseley,et al.  Atrophy and dysfunction of parahippocampal white matter in mild Alzheimer's disease , 2012, Neurobiology of Aging.

[24]  Pablo Villoslada,et al.  Mapping the brain pathways of declarative verbal memory: Evidence from white matter lesions in the living human brain , 2008, NeuroImage.

[25]  Frederik Barkhof,et al.  Extensive Hippocampal Demyelination in Multiple Sclerosis , 2007, Journal of neuropathology and experimental neurology.

[26]  J. DeLuca,et al.  A comparison of memory performance in relapsing-remitting, primary progressive and secondary progressive, multiple sclerosis. , 2001, Neuropsychiatry, neuropsychology, and behavioral neurology.

[27]  Kyle C. Kern,et al.  Regional hippocampal atrophy in multiple sclerosis. , 2008, Brain : a journal of neurology.

[28]  Marco Rovaris,et al.  Interferon beta-1a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: a randomised, double-blind, placebo-controlled trial , 2004, The Lancet.

[29]  Robert Zivadinov,et al.  Neocortical atrophy, third ventricular width, and cognitive dysfunction in multiple sclerosis. , 2006, Archives of neurology.

[30]  Karl J. Friston,et al.  Unified segmentation , 2005, NeuroImage.

[31]  G Luccichenti,et al.  Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing–remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study , 2009, Multiple sclerosis.

[32]  H. Hahn,et al.  Memory performance in multiple sclerosis patients correlates with central brain atrophy , 2006, Multiple sclerosis.

[33]  Chunshui Yu,et al.  Hippocampal volume and asymmetry in mild cognitive impairment and Alzheimer's disease: Meta‐analyses of MRI studies , 2009, Hippocampus.

[34]  C. Polman,et al.  Cognitive impairment and decline in different MS subtypes , 2006, Journal of the Neurological Sciences.

[35]  Dieter Vaitl,et al.  Evidence for a direct association between cortical atrophy and cognitive impairment in relapsing–remitting MS , 2006, NeuroImage.

[36]  Amity E. Green,et al.  Automated 3D mapping of hippocampal atrophy and its clinical correlates in 400 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls , 2009, Human brain mapping.

[37]  M. Ron,et al.  Cognitive impairment in relapsing—remitting multiple sclerosis can be predicted by imaging performed several years earlier , 2008, Multiple sclerosis.

[38]  Alan C. Evans,et al.  A nonparametric method for automatic correction of intensity nonuniformity in MRI data , 1998, IEEE Transactions on Medical Imaging.

[39]  A. Thompson,et al.  Early imaging predicts later cognitive impairment in primary progressive multiple sclerosis , 2010, Neurology.

[40]  Nick C Fox,et al.  Interactive algorithms for the segmentation and quantitation of 3-D MRI brain scans. , 1997, Computer methods and programs in biomedicine.

[41]  P. Sachdev,et al.  In Vivo Hippocampal Measurement and Memory: A Comparison of Manual Tracing and Automated Segmentation in a Large Community-Based Sample , 2009, PloS one.